Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $533,378 | 244 | 89.5% |
| Travel and Lodging | $32,099 | 206 | 5.4% |
| Food and Beverage | $17,566 | 728 | 2.9% |
| Consulting Fee | $11,025 | 5 | 1.8% |
| Honoraria | $1,688 | 1 | 0.3% |
| Education | $175.84 | 11 | 0.0% |
| Gift | $40.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $313,668 | 468 | $0 (2024) |
| Allergan, Inc. | $145,803 | 458 | $0 (2021) |
| ABBVIE INC. | $92,797 | 166 | $0 (2024) |
| ITI, Inc. | $37,486 | 50 | $0 (2023) |
| Axsome Therapeutics, Inc. | $2,908 | 4 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,181 | 2 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $266.89 | 22 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $253.96 | 10 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $204.32 | 3 | $0 (2022) |
| Ironshore Pharmaceuticals Inc. | $97.91 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,961 | 14 | Alkermes, Inc. ($7,438) |
| 2023 | $52,644 | 65 | Alkermes, Inc. ($27,828) |
| 2022 | $105,231 | 171 | Alkermes, Inc. ($49,813) |
| 2021 | $93,687 | 185 | AbbVie Inc. ($44,193) |
| 2020 | $75,717 | 176 | Allergan, Inc. ($44,223) |
| 2019 | $68,672 | 184 | Alkermes, Inc. ($42,726) |
| 2018 | $67,872 | 173 | Alkermes, Inc. ($35,523) |
| 2017 | $120,188 | 228 | Alkermes, Inc. ($80,063) |
All Payment Transactions
1,196 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/10/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,500.00 | General |
| Category: CNS | ||||||
| 06/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: CNS | ||||||
| 06/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $303.97 | General |
| Category: CNS | ||||||
| 06/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $69.46 | General |
| Category: CNS | ||||||
| 06/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $46.34 | General |
| Category: CNS | ||||||
| 06/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: CNS | ||||||
| 06/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: CNS | ||||||
| 06/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: CNS | ||||||
| 06/08/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: CNS | ||||||
| 06/07/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $121.20 | General |
| Category: CNS | ||||||
| 06/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $92.03 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,160.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: PSYCHIATRY | ||||||
| 10/26/2023 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,780.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/26/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2023 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $540.00 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $33.71 | General |
| Category: Central Nervous System | ||||||
| 09/13/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,050.00 | General |
| Category: CNS | ||||||
| 09/05/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: CNS | ||||||
| 09/05/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: CNS | ||||||
| 08/31/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $31.77 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/24/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $68.83 | General |
| Category: CNS | ||||||
| 08/14/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | Cash or cash equivalent | $83.81 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 73 | 90 | $8,430 | $3,774 |
| 2022 | 2 | 113 | 280 | $30,834 | $18,660 |
| 2021 | 5 | 291 | 362 | $38,516 | $23,850 |
| 2020 | 5 | 412 | 540 | $43,772 | $26,000 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 54 | 71 | $7,100 | $2,921 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 19 | $1,330 | $852.72 | 64.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 88 | 254 | $25,400 | $16,255 | 64.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 25 | 26 | $5,434 | $2,404 | 44.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 69 | 115 | $12,124 | $8,427 | 69.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 57 | 60 | $12,540 | $8,248 | 65.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2021 | 74 | 87 | $8,004 | $4,855 | 60.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 47 | 56 | $3,472 | $2,014 | 58.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 44 | 44 | $2,376 | $305.27 | 12.8% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 103 | 153 | $14,076 | $8,853 | 62.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 91 | 119 | $9,996 | $5,366 | 53.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 104 | 129 | $6,966 | $4,937 | 70.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 86 | 111 | $6,882 | $4,116 | 59.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2020 | 28 | 28 | $5,852 | $2,728 | 46.6% |
About Dr. Manmohan Singh, MD
Dr. Manmohan Singh, MD is a Psychiatry healthcare provider based in Des Moines, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205821337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manmohan Singh, MD has received a total of $595,970 in payments from pharmaceutical and medical device companies, with $11,961 received in 2024. These payments were reported across 1,196 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($533,378).
As a Medicare-enrolled provider, Singh has provided services to 889 Medicare beneficiaries, totaling 1,272 services with total Medicare billing of $72,283. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Des Moines, IA
- Active Since 09/14/2005
- Last Updated 05/20/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1205821337
Products in Payments
- VRAYLAR (Drug) $238,387
- ARISTADA (Drug) $135,824
- Aristada 441 mg (Drug) $115,305
- LYBALVI (Drug) $62,132
- CAPLYTA (Drug) $39,667
- Auvelity (Drug) $2,908
- REXULTI (Drug) $289.41
- AUSTEDO (Drug) $233.18
- VIIBRYD (Drug) $202.01
- Vivitrol 380 mg (Drug) $132.11
- VIVITROL (Drug) $125.00
- SPRAVATO (Drug) $123.16
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $97.91
- LATUDA (Drug) $88.91
- INVEGA SUSTENNA (Drug) $81.16
- SUNOSI (Drug) $61.75
- QUVIVIQ (Drug) $57.40
- Austedo XR (Drug) $33.71
- Azstarys (Drug) $31.77
- HETLIOZ (Drug) $28.90
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Des Moines
Dr. Thomas Koithan, Do, DO
Psychiatry — Payments: $7,961
Cynthia Coenen, Arnp/Pmhnp-Bc, ARNP/PMHNP-BC
Psychiatry — Payments: $5,982
Leonard Richards, Do, DO
Psychiatry — Payments: $2,806
Dr. J Patrick Bertroche, D.o, D.O
Psychiatry — Payments: $680.34
Dr. Martin Fialkov, M.d, M.D
Psychiatry — Payments: $538.08
Dr. Ketan Dhadphale, M.d, M.D
Psychiatry — Payments: $526.17